Study identifies quorum-sensing dependent promoters enhancing 2,4-DAPG and β-galactosidase in Pseudomonas bijieensis, suggesting a novel platform for biotechnology applications.
Pseudomonas bijieensis 2P24, a bacterium isolated from the wheat rhizosphere, is known for producing secondary metabolites such as 2,4-diacetylphloroglucinol (2,4-DAPG), which exhibits strong inhibitory effects against soil-borne pathogens. The genome of P. bijieensis 2P24 also harbors the mupirocin biosynthetic gene cluster, underscoring its metabolic versatility and potential applications in pharmaceuticals. Within the mupirocin biosynthetic gene cluster, a luxI/luxR -type quorum-sensing system (MupI/MupR) regulates secondary metabolites production, linking quorum sensing to metabolic processes. Owing to its cost-effective growth conditions, P. bijieensis 2P24 has emerged as a promising candidate for microbial chassis and recombinant protein expression system. In this study, six strong promoters were identified using RNA-seq and ChIP-seq analyses of the quorum-sensing transcriptional regulator MupR, combined with an enhanced green fluorescent protein reporter system. These promoters were evaluated in the autologous 2,4-DAPG biosynthetic pathway and β-galactosidase expression in P. bijieensis 2P24. The quorum-sensing-dependent promoters significantly enhanced 2,4-DAPG production, while all six promoters demonstrated robust β-galactosidase activity with consistent performance. These findings highlight the potential of endogenous strong promoters for optimizing metabolic pathways and recombinant protein production, especially under quorum-sensing regulation. This study establishes P. bijieensis 2P24 as an effective platform for applications in agriculture, pharmaceuticals, and biotechnology.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: